The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.
Immunology • Vol. 160, Issue 1 • 2020
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
The Journal of dermatology • Vol. 42, Issue 2 • 2015
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Pharmacological reviews • Vol. 67, Issue 3 • 2015
The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.
The Journal of pharmacology and experimental therapeutics • Vol. 350, Issue 1 • 2014